Compare HPE & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HPE | VEEV |
|---|---|---|
| Founded | 1939 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2B | 36.9B |
| IPO Year | N/A | 2013 |
| Metric | HPE | VEEV |
|---|---|---|
| Price | $22.01 | $242.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 27 |
| Target Price | $26.13 | ★ $299.92 |
| AVG Volume (30 Days) | ★ 23.1M | 1.6M |
| Earning Date | 12-04-2025 | 11-20-2025 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | N/A | ★ 26.69 |
| EPS | N/A | ★ 5.13 |
| Revenue | ★ $34,296,000,000.00 | $3,080,246,000.00 |
| Revenue This Year | $20.20 | $17.74 |
| Revenue Next Year | $5.84 | $12.24 |
| P/E Ratio | ★ N/A | $46.66 |
| Revenue Growth | 13.84 | ★ 15.96 |
| 52 Week Low | $11.97 | $201.54 |
| 52 Week High | $26.44 | $310.50 |
| Indicator | HPE | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 33.84 | 59.60 |
| Support Level | $23.73 | $217.88 |
| Resistance Level | $24.39 | $226.50 |
| Average True Range (ATR) | 0.54 | 4.67 |
| MACD | -0.28 | 4.12 |
| Stochastic Oscillator | 8.18 | 91.93 |
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.